A Comparative Study on the Effect of Doshahara Basti and Vaitarana Basti in the management of Amavata
AbstractIn present era 80% of the disorders in the world are of Samarogas. Out of them the most crippling disorder, which hampers the economy of the world as well as the individual, are musculo-skeletal disorders. These are best known as Rheumatic disorders. Out of them many disorders have got signs & symptoms similar to Amavata. So the Amavata description given in the Madhavanidana covers a variety of Rheumatological disorders. Due to wide spectrum of disease, much prevalence in the society and lack of effective medicament, the disease is being chosen for the study. This research study was conducted on 30 patients with classical sign & symptoms of Amavata by adopting proper assessment criteria. In group A 15 patients were treated with Prasarini Taila and Doshahara Basti for 8 consecutive days. In group B 15 patients were treated with Prasarini Taila and Vaitarana Basti for 8 consecutive days. The pharmacodynamic property of Basti dravyas are having Laghu- Tikshna guna, Katu-Tikta rasa, Ushna virya are against the Guru, Pichchila, Sheeta properties of Ama. Thus Basti proves an effective treatment in Amavata. The overall effect of therapy in Group A was 78.57 % and in Group B was 51.19%.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.